ID,Seed,Run time,Rate of gonorrhea cases (average incidence after epidemic warm-up),Time-averaged proportion of cases CIP-S (average incidence after epidemic warm-up),Time-averaged proportion of cases TET-S (average incidence after epidemic warm-up),Time-averaged proportion of cases CRO-S (average incidence after epidemic warm-up),Time-averaged proportion of cases CIP/TET-NS (average incidence after epidemic warm-up),"Time-averaged proportion of cases treated successfully with CIP, TET, or CRO (average incidence after epidemic warm-up)",Time-averaged proportion of cases treated successfully with CIP (average incidence after epidemic warm-up),Time-averaged proportion of cases treated successfully with TET (average incidence after epidemic warm-up),Time-averaged proportion of cases treated successfully with CRO (average incidence after epidemic warm-up),Duration of 1st line therapy with CRO (after epidemic warm-up),Duration of 1st line therapy with Drug M (after epidemic warm-up)
0,1763909319,5.398213148117065,0.06878336097602314,0.6841943025087877,0.1731907031476658,0.9529663638047391,0.8009421136568784,0.43595308322294335,0.0,0.0,0.43595308322294335,10.0,14.0
1,1489933983,5.442432641983032,0.060335978465608404,0.7507692105778605,0.1483324552776104,0.9559661561847641,0.8231171960009905,0.5552579061987077,0.0,0.0,0.5552579061987077,13.0,11.0
